European Association for the Study of the Liver (EASL 2026) – ARO‑INHBE demonstrates clinically meaningful reductions in liver fat as monotherapy and in combination with low-dose tirzepatide in adults with obesity
May 27 - May 30, 2026
Supporting Materials
View Presentation 326.1 KB